Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Matrilysin (MMP-7) is implicated in tumor development.
• TNF-family proteins are substrates for MMP-7, influencing apoptosis.
• MMP-7 exhibits both pro-apoptotic and tumor-promoting functions.

Purpose of the Study:

• To reconcile the dual roles of matrilysin (MMP-7) in apoptosis and tumor promotion.
• To investigate MMP-7's impact on cancer cell sensitivity to death receptor-mediated apoptosis.

Main Methods:

• Utilized human HBL100 and murine NMuMG cell lines representing early tumor progression.
• Assessed cell death upon matrilysin exposure, blocked by FasL neutralizing antibodies.
• Evaluated Fas-mediated apoptosis sensitivity in matrilysin-expressing cells using receptor-activating antibodies and splenocytes.
• Tested sensitivity to chemical apoptosis inducers in matrilysin-expressing cells.

Main Results:

• Matrilysin exposure induced cell death in HBL100 and NMuMG cells, inhibited by FasL antibodies.
• Constitutive matrilysin expression selected for cells with reduced sensitivity to Fas-mediated apoptosis.
• Matrilysin-expressing cells demonstrated significantly lower sensitivity to chemical apoptosis inducers.

Conclusions:

• Early-stage tumor expression of matrilysin (MMP-7) selects for apoptosis-resistant cells.
• This resistance may allow cells to evade immune surveillance, promoting tumor progression.
• MMP-7 contributes to tumor development by facilitating the acquisition of further genetic modifications.